EPIK-L1
Novartis
Novartis
Palvella Therapeutics, Inc.
Yonsei University
Murdoch Childrens Research Institute
Boston Children's Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Palvella Therapeutics, Inc.
Stanford University
FDA Office of Orphan Products Development